Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Exchange Rate Effect (2023 - 2025)

Gyre Therapeutics (GYRE) has disclosed Exchange Rate Effect for 3 consecutive years, with $127000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 149.8% to $127000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $343000.0 through Dec 2025, up 225.64% year-over-year, with the annual reading at $343000.0 for FY2025, 225.64% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $127000.0 at Gyre Therapeutics, up from $117000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $231000.0 in Q4 2023, with the low at -$900000.0 in Q2 2023.
  • Average Exchange Rate Effect over 3 years is -$19000.0, with a median of $78000.0 recorded in 2024.
  • The sharpest move saw Exchange Rate Effect plummeted 210.39% in 2024, then skyrocketed 208.7% in 2025.
  • Over 3 years, Exchange Rate Effect stood at $231000.0 in 2023, then tumbled by 210.39% to -$255000.0 in 2024, then surged by 149.8% to $127000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $127000.0, $117000.0, and $49000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.